Reinitiating antiplatelet therapy in chronic subdural hematoma: Does adjunctive middle meningeal artery embolization improve outcomes?
Muhammed Amir Essibayi·Dhairya A. Lakhani·Huanwen Chen·Ahmed Y. Azzam·Adam A. Dmytriw·Vivek S Yedavalli·Mohammad A. Kassar·Neil Haranhalli·Hamza Salim·Marco Colasurdo·Dheeraj Gandhi·Deepak Khatri·David J. Altschul·Jay Kakadiya
Abstract The optimal timing for reinitiating antiplatelet therapy after treatment of chronic subdural hematoma (cSDH) remains uncertain, especially when middle meningeal artery embolization (MMAE) is used as an adjunct to surgery. This study evaluated the safety and outcomes of early antiplatelet reinitiation in patients undergoing combined surgical evacuation and MMAE, and compared outcomes in antiplatelet-treated patients receiving surgery with versus without MMAE. Adult cSDH patients from the